The Danish Board on Research Misconduct (DBRM) is Denmark’s single, centralized, government-level authority for investigating and ruling on allegations of research misconduct — fabrication, falsification, and plagiarism (FFP) — across all fields of Danish publicly funded research. It replaced the older Danish Committees on Scientific Dishonesty (UVVU) on 1 July 2017, when Denmark’s Act on Research Misconduct came into force. Unlike the institution-led investigation models used in the United States or the United Kingdom, Denmark places misconduct determinations with a national body outside the researcher’s own university, while pushing the lower-severity category of “questionable research practice” down to individual institutions to handle themselves.
This guide covers what the Board is, how it differs from UVVU, its legal basis and composition, how a case actually moves from a complaint to a binding decision, and how Denmark’s centralized model compares with the other national research-integrity systems CASRAI has profiled.
From UVVU to the Danish Board on Research Misconduct
Denmark was one of the first countries in the world to create a standing national body for research misconduct, establishing the Danish Committees on Scientific Dishonesty (Udvalgene Vedrørende Videnskabelig Uredelighed, UVVU) in 1992, initially on a trial basis. UVVU was not a single body but three separate committees, sharing a common chairman: one for natural, agricultural/veterinary, and technical science; one for health and medical science; and one for social science and the humanities. Originally scoped narrowly around the health sciences, UVVU’s remit was broadened in 1999 to cover all fields of research.
That structure was replaced on 1 July 2017, when the Danish Parliament’s Act on Research Misconduct (Lov om videnskabelig uredelighed m.v.) took effect, dissolving the three UVVU committees and creating the single Danish Board on Research Misconduct (DBRM) in their place. The reform did two things at once: it gave Denmark statutory definitions of misconduct for the first time, and it shifted a meaningful share of the workload — everything below the FFP threshold — onto the research institutions themselves, who had previously had a much smaller formal role.
Legal Basis
The Board’s authority rests on three layered instruments:
- The Act on Research Misconduct (2017), the primary statute establishing the Board, defining misconduct, and setting its procedure and powers.
- The Danish Act on Public Administration, which governs the Board’s administrative procedure as a public authority (case handling, party rights, documentation).
- The Danish Code of Conduct for Research Integrity, the national framework of good-practice norms that questionable-research-practice assessments at institutions are measured against.
Administratively, the Board sits under Denmark’s Ministry of Higher Education and Science (Uddannelses- og Forskningsministeriet), with its secretariat funded through the state budget and housed within the Ministry’s agency, but it operates independently of the Ministry in its casework and rulings — the Minister’s oversight role is limited to supervising compliance with the Act, not to reviewing individual decisions.
Structure and Composition
The Board is chaired by a sitting or retired High Court judge, appointed by the Minister for a four-year term that can be extended to six years. Alongside the chair sit eight to ten academic members drawn from a range of scientific disciplines, each with a personal alternate; both hold voting rights, and the chair casts the deciding vote in the event of a tie. This judge-chaired, discipline-diverse composition is deliberate: it pairs legal/administrative rigor with subject-matter competence across the natural sciences, health sciences, social sciences, and humanities in a single national panel, rather than splitting jurisdiction by field as UVVU’s three committees once did.
Research Misconduct vs. Questionable Research Practice
The 2017 Act draws a sharp statutory line between two tiers, and which tier a case falls into determines who investigates it.
Research misconduct (handled exclusively by the Board) is defined as fabrication, falsification, and plagiarism committed willfully or with gross negligence in planning, conducting, or reporting research:
- Fabrication — the undisclosed construction of data, or substitution of real data with fictitious data.
- Falsification — manipulation of research material, equipment, or processes, or inappropriately altering or omitting data or results.
- Plagiarism — appropriating another person’s ideas, processes, results, text, or data without giving due credit.
Questionable research practice — a violation of generally accepted responsible-research-practice norms that falls short of willful or grossly negligent FFP — is explicitly carved out of the Board’s jurisdiction and left to the individual research institution to assess and resolve under the Danish Code of Conduct for Research Integrity. This two-tier split is the single most distinctive feature of the Danish model relative to systems like the German OWID/DFG framework or the Dutch LOWI process, both of which route most cases through institution-level committees with a national body available on appeal or second opinion, rather than splitting jurisdiction by severity from the outset. Related concept: questionable research practices and research misconduct.
How a Case Reaches the Board
Denmark’s process is institution-first even for cases that end up with the Board:
- Complaint at the institution. An allegation is first brought to the research institution where the work was conducted. The institution makes an initial assessment of whether it plausibly meets the statutory misconduct criteria and prepares a factual report.
- Referral to the Board. If the institution’s assessment indicates possible research misconduct (as opposed to a lesser questionable-practice issue it can handle itself), the case is forwarded to the Board.
- Jurisdiction check. The Board only takes up cases concerning researchers who are PhD students or hold a doctoral-level qualification, working on publicly funded research or at a Danish public research institution. Complaints touching privately funded research require the funding company’s consent to proceed. The Board can decline to examine a case that falls outside its statutory authority, is manifestly ungrounded, would involve disproportionate processing costs, or has only a minimal connection to Denmark.
- Investigation and decision. Rejected cases receive a decision within roughly three months; cases the Board takes up are expected to conclude within twelve months, extendable in complex matters.
Compare this against institutional vs. federal jurisdiction in U.S. misconduct cases or the general mechanics described in how a research misconduct investigation actually works — Denmark’s institution-first triage followed by a single centralized decision-maker sits between the fully decentralized U.S. model (where institutions investigate and ORI oversees federally funded research) and fully centralized models elsewhere.
Decisions, Consequences, and Appeal
The Board’s opinions are administratively binding and are not subject to appeal to another administrative authority. Where the Board finds misconduct, it can require the researcher to withdraw or correct the affected publication and can notify the researcher’s institution, employer, relevant journal editors, and funding bodies of the finding. The institution and the Board both have a role in monitoring that any required corrective measures are actually carried out. The Minister for Higher Education and Science supervises overall compliance with the Act, but does not sit in judgment on individual cases.
Transparency: Decisions and Annual Reports
The Board publishes its (anonymized) decisions and issues annual reports, in Danish, summarizing caseload and outcomes for the year — the closest Danish equivalent to the case-summary transparency that bodies like the U.S. Office of Research Integrity or the UK’s UKRIO provide, though decisions are anonymized rather than named, consistent with Denmark’s public-administration confidentiality norms for individual cases.
Denmark in Context: How the Model Compares
The Danish Board on Research Misconduct is part of a broader pattern CASRAI has tracked across national research-integrity systems — some centralized and government-run, others institution-led with an ombuds or review layer:
- Centralized, government-level bodies similar in spirit to Denmark’s: France’s OFIS, and South Korea’s NRF Research Ethics Center / KUCRE.
- Institution-first with a national second-opinion or review body: the Netherlands’ LOWI, and Germany’s OWID/DFG Code of Conduct system.
- Funder-led investigation processes: Canada’s Tri-Agency SRCR/PRCR framework, and the U.S. Office of Research Integrity, which oversees institution-led investigations of PHS-funded research rather than investigating directly.
- Process-review rather than fact-finding bodies: Australia’s ARIC, which reviews whether an institution’s process was sound rather than re-investigating the substance.
- Non-statutory, membership-based models: New Zealand’s Royal Society Code and the UK’s UKRIO, both advisory rather than binding on institutions by law.
- National frameworks coordinating multiple bodies: South Africa’s ASSAf/DHET/NRF/CHE/USAf framework and Japan’s MEXT guidelines, which combine national guidance with mandatory institutional RCR education.
Denmark’s distinguishing feature within this landscape is the combination of a single national decision-maker with statutory, binding authority over FFP findings, paired with an explicit legal handoff of everything below that threshold to the institutions — a split that most other systems in this comparison series don’t draw as cleanly. For the general vocabulary underlying all of these systems, see the CASRAI Research Integrity & Compliance hub and the research misconduct and questionable research practices definitions.
Frequently Asked Questions
What is the Danish Board on Research Misconduct?
It is Denmark’s single national authority for investigating and ruling on allegations of research misconduct — fabrication, falsification, and plagiarism — across all fields of publicly funded Danish research. It was created by the 2017 Act on Research Misconduct and sits administratively under the Ministry of Higher Education and Science, though it decides cases independently of the Ministry.
When did the Board replace UVVU, and why?
The Board took over from the three Danish Committees on Scientific Dishonesty (UVVU) on 1 July 2017, when the Act on Research Misconduct came into force. The reform introduced Denmark’s first statutory definitions of misconduct and shifted responsibility for lower-severity “questionable research practice” cases to individual institutions, leaving the national Board to focus solely on fabrication, falsification, and plagiarism.
Is the Board part of a university, or a government body?
It is a government-level body, not an institution-led committee. It is administratively housed under Denmark’s Ministry of Higher Education and Science and funded through the state budget, but it operates independently of the Ministry when deciding individual cases.
What is the difference between research misconduct and questionable research practice in Denmark?
Research misconduct is fabrication, falsification, or plagiarism committed willfully or with gross negligence, and only the Board can rule on it. Questionable research practice covers other violations of accepted research-practice norms that fall short of that threshold, and Danish institutions handle those cases themselves under the Danish Code of Conduct for Research Integrity.
Can a researcher appeal a decision of the Board?
The Board’s opinions are administratively binding and are not subject to appeal to another administrative authority, which reflects its position as a specialized, judge-chaired national tribunal rather than a first-instance administrative office.
Does the Board handle privately funded research?
The Board’s jurisdiction centers on publicly funded research and researchers at Danish public institutions who are PhD students or hold a doctoral-level qualification. Cases touching privately funded research require the consent of the funding company before the Board can proceed.
Where can I find the Board’s decisions and reports?
The Board publishes anonymized decisions and annual reports, in Danish, summarizing its caseload and outcomes, via Denmark’s Ministry of Higher Education and Science (ufm.dk).
